<DOC>
	<DOC>NCT01369810</DOC>
	<brief_summary>To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure</brief_summary>
	<brief_title>Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Epidemiological</keyword>
	<keyword>asthma</keyword>
	<keyword>COPD</keyword>
	<keyword>reimbursement</keyword>
	<keyword>switch</keyword>
	<keyword>outcomes associated with the change in reimbursement</keyword>
</DOC>